Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Buntanetap

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Annovis Bio Regains NYSE Listing Compliance
    Annovis Bio Regains NYSE Listing Compliance

    26 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/26/3301048/0/en/annovis-bio-regains-nyse-listing-compliance.html

    GLOBENEWSWIRE
    26 May 2026
    Share Share
    Annovis Prices $15M Public Offering with Warrants
    Annovis Prices $15M Public Offering with Warrants

    20 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/20/3298420/0/en/annovis-announces-pricing-of-15-0-million-public-offering-of-common-stock-and-accompanying-warrants.html

    GLOBENEWSWIRE
    20 May 2026
    Share Share
    Annovis Announces Public Offering of Stock and Warrants
    Annovis Announces Public Offering of Stock and Warrants

    19 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/19/3297958/0/en/annovis-announces-launch-of-proposed-public-offering-of-common-stock-and-accompanying-warrants.html

    GLOBENEWSWIRE
    19 May 2026
    Share Share
    Annovis Reports Q1 2026 Financial Results
    Annovis Reports Q1 2026 Financial Results

    15 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/15/3295755/0/en/annovis-provides-corporate-updates-and-reports-first-quarter-2026-financial-results.html

    GLOBENEWSWIRE
    15 May 2026
    Share Share
    Annovis Releases Alzheimer's Phase 2/3 Trial Results In Nature
    Annovis Releases Alzheimer's Phase 2/3 Trial Results In Nature

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3282572/0/en/annovis-publishes-phase-2-3-alzheimer-s-trial-results-in-nature-portfolio.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    Annovis Raises $10M for Ph 3 Alzheimer Disease's NDA Submission
    Annovis Raises $10M for Ph 3 Alzheimer Disease's NDA Submission

    10 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/10/3271713/0/en/Annovis-Closes-10-Million-Offering-Extending-Cash-Runway-Through-Phase-3-Alzheimer-s-Disease-6-Month-NDA-Submission.html

    GLOBENEWSWIRE
    10 Apr 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.